Management of onychomycosis and awareness of guidelines among dermatologists [5]

British Journal of Dermatology

Volumn 155, Issue 5, 2006, Pages 1080-1082

  Rajpar, S F ^a   Abdullah, A ^a  

^a SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOROLFINE; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; TERBINAFINE;

ADJUVANT THERAPY; AVULSION INJURY; CLINICAL TRIAL; COMORBIDITY; DERMATOPHYTE; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG TREATMENT FAILURE; EVIDENCE BASED MEDICINE; FINGERNAIL ONYCHOMYCOSIS; HEALTH SURVEY; HUMAN; INTERNET; LETTER; MEDICAL SPECIALIST; MICROSCOPY; ONYCHOMYCOSIS; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; SAMPLE SIZE; TOENAIL ONYCHOMYCOSIS; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; CLINICAL COMPETENCE; DERMATOLOGY; GREAT BRITAIN; HUMANS; ONYCHOMYCOSIS; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC;

EID: 33749870132     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07493.x     Document Type: Letter

References (11)

1. Roberts DT, Taylor WD, Boyle J. Guidelines for the treatment of onychomycosis. Br J Dermatol 2003; 148:402-10.
2. Hull PR, Gupta AK, Summerbell RC. Onychomycosis: an evaluation of three sampling methods. J Am Acad Dermatol 1998; 39:1015-17.
3. Gupta AK, Jain HC, Lynde CW et al. Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter Canadian survey of 15,000 patients. J Am Acad Dermatol 2000; 43:244-8.
4. Krob AH, Fleischer AB, D'Agostino R et al. Terbinafine is more effective than itraconazole in treating toenail onychomycosis: results from a meta-analysis of randomized controlled trials. J Cutan Med Surg 2003; 7:306-11.
5. Havu V, Heikkila H, Kuokkanen K et al. A double-blind, randomized study to compare the efficacy and safety of terbinafine (Lamisil) with fluconazole (Diflucan) in the treatment of onychomycosis. Br J Dermatol 2000; 142:97-102.
6. Faergemann J, Anderson C, Herlse K et al. Double-blind, parallel group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis. J Am Acad Dermatol 1995; 32:750-3.
7. Gupta AK, Ryder JE, Johnson AM. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. Br J Dermatol 2004; 150:537-44.
8. Baran R. Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis. Br J Dermatol 2001; 145 (Suppl. 60):15-19.
9. Hay RJ, Baran R, Haneke E. Fungal (onychomycosis) and other infections involving the nail apparatus. In: Baran and Dawber's Diseases of the Nails and their Management (Baran R, Dawber RPR, de Berker DAR, Haneke E, Tosti A, eds), 3rd edn. Oxford: Blackwell Science, 2001; 129-71.
10. Watson A, Marley J, Ellis D et al. Terbinafine in onychomycosis of the toenail: a novel treatment protocol. J Am Acad Dermatol 1995; 33:775-9.
11. Griffiths CEM. The British Association of Dermatologists guidelines for the management of skin disease. Br J Dermatol 1999; 141:396-7.